id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3719-6965,FDA,FDA-2015-D-3719,Part 15 Hearing Transcript Day 1 091216-FDA-CBER,Supporting & Related Material,Background Material,2017-08-24T04:00:00Z,2017,8,,,2017-08-24T20:30:54Z,,0,0,0900006482ab931e
FDA-2015-D-3719-6966,FDA,FDA-2015-D-3719,Part 15 Hearing Transcript Day 2 091316-FDA-CBER,Supporting & Related Material,Background Material,2017-08-24T04:00:00Z,2017,8,,,2017-08-24T20:31:40Z,,0,0,0900006482ab931f
FDA-2015-D-3719-0444,FDA,FDA-2015-D-3719,Compliance Policy Guide Cover Memo,Supporting & Related Material,Background Material,2016-09-29T04:00:00Z,2016,9,,,2016-09-29T18:17:56Z,,0,0,090000648228140e
FDA-2015-D-3719-0445,FDA,FDA-2015-D-3719,Compliance Policy Guide,Supporting & Related Material,Background Material,2016-09-29T04:00:00Z,2016,9,,,2016-09-29T18:19:06Z,,0,0,090000648228140f
FDA-2015-D-3719-0018,FDA,FDA-2015-D-3719,"Draft Guidances Relating to the Regulation of Human Cells, Tissues,
and Cellular and Tissue-Based Products; Rescheduling of Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2016-04-22T04:00:00Z,2016,4,2016-04-22T04:00:00Z,2016-09-28T03:59:59Z,2016-10-27T01:00:38Z,2016-09372,0,0,0900006481f831b9
FDA-2015-D-3719-0002,FDA,FDA-2015-D-3719,"Draft Guidances Relating to the Regulation of Human Cells, Tissues, or
Cellular or Tissue-Based Products; Public Hearing; Request for Comments; Correction",Proposed Rule,Notice of Hearing,2015-12-29T05:00:00Z,2015,12,2015-12-29T05:00:00Z,,2015-12-29T15:40:51Z,2015-32686,0,0,0900006481dd7b11
FDA-2015-D-3719-0001,FDA,FDA-2015-D-3719,"Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2015-10-30T04:00:00Z,2015,10,2015-10-30T04:00:00Z,2016-04-30T03:59:59Z,2024-11-12T05:48:23Z,2015-27703,1,0,0900006481cfca62